Effect of respiratory tube on pneumonia occurrence in patients admitted to intensive care unit

Effect of bactiguard infection protection endotracheal tube on ventilator-associated pneumonia occurrence in patients admitted to intensive care unit

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N132

Enrollment

108

Registered

2020-01-29

Start date

2018-04-21

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventilator-associated pneumonia. Ventilator associated pneumonia

Interventions

Intervention 1: Intervention group 1:Patients who enter the first group will receive a BIP endotracheal tube (Nova tex Co). The endotracheal tube is inserted into the section from the beginning.The en

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 18 to 60 years A level of consciousness less than 10

Exclusion criteria

Exclusion criteria: No history of pulmonary disease No pulmonary involvement

Design outcomes

Primary

Measure	Time frame
Volume of discharge. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Milliliter.;Leukocytosis. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Blood test.;Decrease in oxygen saturation. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Pulse Oximeter.;Fever. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Thermometer.;Illness severity. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: APACHE II score.	—

Measure

Time frame

Volume of discharge. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Milliliter.;Leukocytosis. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Blood test.;Decrease in oxygen saturation. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Pulse Oximeter.;Fever. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: Thermometer.;Illness severity. Timepoint: Before start intervention and first and second days after intervention. Method of measurement: APACHE II score.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 68 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026